Prot #017004: An Open-Label, Phase 1 Safety and Phase 2 Randomized Study of JCAR017 in Subjects with Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (017004)

Project: Research project

Project Details

StatusActive
Effective start/end date1/18/191/18/22

Funding

  • DrugDev Inc. (Prot #017004)
  • Juno Therapeutics, Inc. (Prot #017004)